MAT-MALTA ADVANCED TECHNOLOGIES LIMITED;FREISTAAT BAYERN REPRESENTED BY JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG
发明人:
Jan Wesjohann,Günter Sprotte,Ana Maria Waaga-Gasser
申请号：
US15433497
公开号：
US20170252438A1
申请日:
2017.02.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the use of a composition selected from the group consisting of antibodies, antibody fragments, insulin-like growth factor antagonists, Toll-like receptor antagonists and mixtures thereof for the treatment or the prophylaxis of certain diseases.
